Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0700
+0.0050 (7.69%)
Jun 22, 2026, 3:06 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 3.46 million as of June 18, 2026. Its market cap has decreased by -57.11% in one year.
Market Cap
3.46M
Enterprise Value
953.18K
Revenue
9.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 3.46M, a decrease of -96.45%. That is a compound annual growth rate of -46.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 3.46M | -57.93% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invex Therapeutics | 9.77M |
| Vectus Biosystems | 9.22M |
| AdAlta | 7.97M |
| Acrux | 7.70M |
| Biotron | 6.75M |
| Bio-Gene Technology | 6.10M |
| Tissue Repair | 6.05M |
| Zelira Therapeutics | 5.95M |